Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Xtl Biopharmaceuticals Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Jun. 12, 2024)Obesity, fitness, & wellness week, 2024-06, p.1906NewsRX LLCTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Xtl Biopharmaceuticals Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (May 13, 2024)Obesity, fitness, & wellness week, 2024-06, p.2295NewsRX LLCTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Xtl Biopharmaceuticals Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Apr. 30, 2024)Obesity, fitness, & wellness week, 2024-05, p.1940NewsRX LLCTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Xtl Biopharmaceuticals Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Apr. 2, 2024)Obesity, fitness, & wellness week, 2024-04, p.2060NewsRX LLCTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Xtl Biopharmaceuticals Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Mar. 21, 2024)Obesity, fitness, & wellness week, 2024-04, p.2105NewsRX LLCTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Xtl Biopharmaceuticals Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Mar. 20, 2024)Obesity, fitness, & wellness week, 2024-04, p.1844NewsRX LLCTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Mereo Biopharma Group Plc Files SEC Form 424B5, Prospectus [Rule 424Obesity, fitness, & wellness week, 2024-07, p.1786NewsRX LLCTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Mereo Biopharma Group Plc Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Jun. 14, 2024)Obesity, fitness, & wellness week, 2024-07, p.1786NewsRX LLCTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Abvc Biopharma, Inc. Files SEC Form 424B4, Prospectus [Rule 424Obesity, fitness, & wellness week, 2024-06, p.1441NewsRX LLCTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Benitec Biopharma Inc. Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (May 29, 2024)Obesity, fitness, & wellness week, 2024-06, p.1472NewsRX LLCTexto completo disponível |